Intervention

Liquid biopsy

ClinicalTrials.gov intervention label

Clinical trials10
Recruiting1
Common conditions11
Lead sponsors shown10

Clinical trials

10 shown
Studying the Role of Circulating Tumor Cell Clusters in Patients With High-risk Early Breast Cancer, Study GALIANCT07418125 · 2024-02-07
RECRUITING
Pancreatic Cancer Initial Detection Via Liquid BiopsyNCT06283576 · 2024-05-01
ENROLLING_BY_INVITATION
A Study to Compare Tissue and Liquid Biopsies in People With Different Types of CancerNCT05708599 · 2023-03-01
ACTIVE_NOT_RECRUITING
Artificial Intelligence for Help Non-Small Cell Lung Cancer: Measure Cancer Biology and Treatment Response Via ImagingNCT05254132 · 2022-07-01
UNKNOWN
Prospective Study on Resistance-associated Mutations in Metastatic Lung CancerNCT06081270 · 2021-12-12
UNKNOWN
Circulating DNA to Improve Outcome of Oncology PatiEnt. A Randomized StudyNCT04258137 · 2020-09-04
ACTIVE_NOT_RECRUITING
Liquid Biopsy to Reduce Time to Treatment for Advanced Nonsquamous NSCLC Diagnosed at Outside SitesNCT04474613 · 2020-08-27
TERMINATED
Liquid Biopsies and Imaging in Breast CancerNCT04223492 · 2019-01-02
COMPLETED
The Correlation of PD-L1 Expression in Non-small Lung Cancer Tissue and Peripheral Blood T Cell and Serum.NCT03073902 · 2017-03-25
COMPLETED
Correlation Between Tissue and Plasmatic EGFR in CBNPC With EGFR Mutation or Predictive Factor of EGFR MutationNCT03265496 · 2016-07-07
TERMINATED

Trial status mix

ACTIVE_NOT_RECRUITING2
COMPLETED2
TERMINATED2
UNKNOWN2
ENROLLING_BY_INVITATION1
RECRUITING1

Phase mix

NA6

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.